1. A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression. Issue 4 (11th April 2015) Authors: Yarlas, Aaron; Miller, Kate; Wen, Warren; Lynch, Shau Yu; Munera, Catherine; Dain, Bradley; Pergolizzi, Joseph V.; Raffa, Robert; Ripa, Steven R. Journal: Pain practice Issue: Volume 16:Issue 4(2016:Apr.) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain. Issue 1 (January 2015) Authors: Yarlas, Aaron; Miller, Kate; Wen, Warren; Lynch, Shau Yu; Munera, Catherine; Pergolizzi, Joseph V.; Raffa, Robert; Ripa, Steven R. Journal: Postgraduate medicine Issue: Volume 127:Issue 1(2015) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate‐to‐Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials. Issue 3 (20th January 2015) Authors: Yarlas, Aaron; Miller, Kate; Wen, Warren; Lynch, Shau Yu; Ripa, Steven R.; Pergolizzi, Joseph V.; Raffa, Robert B. Journal: Pain practice Issue: Volume 16:Issue 3(2016:Mar.) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Burden of hereditary transthyretin amyloidosis on quality of life. Issue 2 (13th June 2019) Authors: Yarlas, Aaron; Gertz, Morie A.; Dasgupta, Noel R.; Obici, Laura; Pollock, Michael; Ackermann, Elizabeth J.; Lovley, Andrew; Kessler, Asia Sikora; Patel, Pankaj A.; White, Michelle K.; Guthrie, Spencer D. Journal: Muscle & nerve Issue: Volume 60:Issue 2(2019) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey. (23rd February 2018) Authors: Yarlas, Aaron; Rubin, David T; Panés, Julian; Lindsay, James O; Vermeire, Séverine; Bayliss, Martha; Cappelleri, Joseph C; Maher, Stephen; Bushmakin, Andrew G; Chen, Lea Ann; DiBonaventura, Marco Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 5(2018:May) Page Start: 600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics and Telepsychiatry Use During COVID-19 Pandemic. (April 2022) Authors: Bessonova, Leona; Keane, Elizabeth; Achtyes, Eric; Harvey, Philip D.; Kane, John M.; Saklad, Stephen R.; Trotter, Jeffrey; Claxton, Amy; Hatfield, Tiffany; McGrory, James; Noori, Wahidullah; O'Sullivan, Amy K.; Biber, Joshua E.; Kessler, Asia Sikora; Yarlas, Aaron; Velligan, Dawn I. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Editorial response to Aimo et al Quality‐of‐life assessment in amyloid transthyretin amyloidosis. (6th August 2021) Authors: Yarlas, Aaron Journal: European journal of clinical investigation Issue: Volume 51:Number 11(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study. Issue 2 (18th January 2018) Authors: Yarlas, Aaron; D'Haens, Geert; Willian, Mary Kaye; Teynor, Megan Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 2(2018) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study. Issue 2 (18th January 2018) Authors: Yarlas, Aaron; D'Haens, Geert; Willian, Mary Kaye; Teynor, Megan Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Remission Status Predicts Health‐Related Quality of Life for Patients With Mild‐to‐Moderate Ulcerative Colitis Receiving Short‐Term and Long‐Term Daily Therapy With Multimatrix Mesalamine: 1945. (October 2015) Authors: Yarlas, Aaron; D'Haens, Geert; Willshire, Deborah; Teynor, Megan Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗